Online citations, reference lists, and bibliographies.
← Back to Search

Nicotine And Cotinine Elimination Pharmacokinetics In Smokers And Nonsmokers

N. Benowitz, P. Jacob
Published 1993 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Published research suggests that smokers metabolize nicotine and its major metabolite cotinine more rapidly than nonsmokers. To evaluate this possibility, we studied the disposition pharmacokinetics of intravenous deuterium‐labeled nicotine in 11 smokers (administered 2.0 and 0.5 µg/kg/min × 30 minutes) and in 11 nonsmokers (0.5 µg/kg/min). Smokers did not metabolize nicotine more rapidly; the clearance of nicotine normalized for body weight was significantly slower in smokers than in nonsmokers. Cotinine elimination rates were similar in the two groups. The disposition pharmacokinetics of nicotine was similar for the low and high doses in the smokers, indicating that metabolism is dose‐independent. Our findings argue against “metabolic tolerance” as a mechanism for the dose escalation observed in smokers after initiation of smoking. Our findings suggest that nicotine and cotinine kinetic parameters for smokers may be extrapolated to nonsmokers for estimating exposures to environmental tobacco smoke in nonsmokers.
This paper references
10.1111/J.1600-0773.1969.TB00531.X
Effect of nicotine treatment on the metabolism of nicotine in the mouse liver in vitro.
T. Stålhandske (1970)
10.1111/j.2042-7158.1971.tb08770.x
The effect of smoking on nicotine metabolism in vivo in man
A. H. Beckett (1971)
10.1126/science.184.4141.1081
Nicotine Inhibition of the Metabolism of 3,4-Benzopyrene, a Carcinogen in Tobacco Smoke
R. P. Weber (1974)
Comparison of the effect of carbon monoxide and of hypoxic hypoxia. I. In vivo metabolism, distribution and action of hexobarbital.
R. Roth (1976)
10.1126/science.7302577
Biochemical markers.
J. Glass (1981)
10.1016/0041-008X(82)90382-9
Nicotyrine inhibits in vivo metabolism of nicotine without increasing its toxicity.
T. Stålhandske (1982)
Interindividual variability in the metabolism and cardiovascular effects of nicotine in man.
N. Benowitz (1982)
10.1038/clpt.1982.235
Smoking‐induced changes in nicotine disposition: Application of a new HPLC assay for nicotine and its metabolites
G. A. Kyerematen (1982)
10.1016/0304-4165(82)90367-1
Heterogeneity of hepatic nicotine oxidase.
H. Nakayama (1982)
hepatic nicotine oxidase
DE Williams (1982)
ES. Smoking-induced changes in nicotine disposition: application of a new HPLC assay for nicotine and its metabolites. CL1N PHARMACOL THER 1982;32:769-80
ML (1982)
10.1136/jech.38.4.335
Biochemical markers of smoke absorption and self reported exposure to passive smoking.
M. Jarvis (1984)
Department of Health and Human Services. The health consequences of involuntary smoking. A report of the Surgeon General. Washington: DHHS Public Health Service
(1986)
10.1038/clpt.1987.59
Influence of tobacco abstinence on the disposition kinetics and effects of nicotine
Belle L Lee (1987)
10.2105/AJPH.78.6.696
Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure.
M. Jarvis (1988)
10.1002/JLCR.2580251009
Synthesis of optically pure deuterium‐labelled nicotine, nornicotine and cotinine
P. Jacob (1988)
10.1056/NEJM198811173192005
Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.
N. Benowitz (1988)
10.2105/AJPH.79.8.1046
Elimination of cotinine from body fluids: disposition in smokers and nonsmokers.
N. Haley (1989)
10.1016/0006-2952(89)90267-0
Microsomal nicotine metabolism: a comparison of relative activities of six purified rabbit cytochrome P-450 isozymes.
G. Mccoy (1989)
The role of cytochromes P-450 and flavin-containing monooxygenase in the metabolism of (S)-nicotine by rabbit lung.
D. E. Williams (1990)
10.1038/clpt.1990.208
Disposition of nicotine and eight metabolites in smokers and nonsmokers: Identification in smokers of two metabolites that are longer lived than cotinine
Gabriel A Kyerematen (1990)
10.1016/0006-2952(90)90351-K
Metabolism of nicotine by hepatocytes.
G. A. Kyerematen (1990)
Metabolism of nicotine by rat liver cytochromes P-450. Assessment utilizing monoclonal antibodies to nicotine and cotinine.
D. Hammond (1991)
10.1002/BMS.1200200503
Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans.
P. Jacob (1991)
10.1038/clpt.1991.28
Stable isotope studies of nicotine kinetics and bioavailability
N. Benowitz (1991)
10.1038/clpt.1991.138
Stable isotope method for studying transdermal drug absorption: The nicotine patch
N. Benowitz (1991)
10.1021/TX00029A008
Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N'-oxide.
J. Cashman (1992)
Nicotine metabolism by cDNA-expressed human cytochrome P-450s
A. M. Flammang (1992)
10.1016/S0160-3450(15)30662-0
Smoking and drug metabolism.
E. McGuffey (1993)
How tobacco produces drug dependence
JE Henningfield



This paper is referenced by
10.1016/B978-0-12-820490-0.00020-1
Clinical Assessment of ENDPs
S. Pouly (2021)
10.1097/FPC.0000000000000427
Effect of race and glucuronidation rates on the relationship between nicotine metabolite ratio and nicotine clearance
E. Liakoni (2021)
10.1016/J.IJMS.2021.116579
A new method for the simultaneous determination of urinary NNAL and cotinine concentrations using HILIC-MS/MS coupled with PRiME HLB SPE
Xinyue Luo (2021)
10.1016/j.pbb.2021.173223
Subchronic effects of plant alkaloids on anxiety-like behavior in zebrafish
A. Hawkey (2021)
10.1016/B978-0-12-820490-0.00022-5
Residual Risk of Nicotine
C. Mathis (2021)
10.1007/s11356-020-09797-8
Concentrations of serum cotinine across stages of glomerular function among US adult smokers and nonsmokers
R. Jain (2020)
10.1016/j.jchromb.2020.122490
Challenges associated with quantification of selected urinary biomarkers of exposure to tobacco products.
Arezoo Habibagahi (2020)
10.1007/s40262-020-00880-4
Comprehensive Parent–Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies
Lukas Kovar (2020)
10.1016/j.envres.2020.109971
DNA methylation signature of passive smoke exposure is less pronounced than active smoking: The Understanding Society study
P. Hulls (2020)
10.1124/molpharm.120.000100
The Influence of Tobacco Smoke/Nicotine on CYP2A Expression in Human and African Green Monkey Lungs
Yuan Gao (2020)
10.1124/pr.119.018028
More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder
M. Moerke (2020)
10.1080/15563650.2019.1636994
Nicotine intoxication by e-cigarette liquids: a study of case reports and pathophysiology
G. C. Maessen (2019)
10.1093/ntr/nty039
Tobacco Smoking and Brain Endogenous Opioid Release: More Than Nicotine Alone.
E. Domino (2019)
10.1007/s11695-019-04128-4
Self-Reported Smoking Compared to Serum Cotinine in Bariatric Surgery Patients: Smoking Is Underreported Before the Operation
Paula J. D. Wolvers (2019)
10.1016/j.trsl.2019.01.001
Chronic exposure to e‐cig aerosols during early development causes vascular dysfunction and offspring growth deficits
Marcus Orzabal (2019)
10.1124/jpet.118.251413
Towards Further Verification of Physiologically-Based Kidney Models: Predictability of the Effects of Urine-Flow and Urine-pH on Renal Clearance
Takanobu Matsuzaki (2019)
10.1007/s00784-018-2388-z
Determination of nicotine content in teeth submitted to prophylaxis and in-office bleaching by gas chromatography–mass spectrometry (GC-MS)
J. D. de Geus (2018)
10.1016/j.neuro.2018.02.014
Brain derived neurotrophic factor (BDNF), its tyrosine kinase receptor B (TrkB) and nicotine.
R. Machaalani (2018)
10.3390/ijerph15122693
Biomarkers of Exposure to Secondhand and Thirdhand Tobacco Smoke: Recent Advances and Future Perspectives
Sònia Torres (2018)
10.1158/1055-9965.EPI-18-0669
Nicotine-N′-Oxidation by Flavin Monooxygenase Enzymes
Yadira X Perez-Paramo (2018)
10.2174/1570159X15666171016164430
E-cigarettes: Impact of E-liquid Components and Device Characteristics on Nicotine Exposure
E. DeVito (2018)
10.1136/bmjopen-2017-019850
Protocol to assess the impact of tobacco-induced volatile organic compounds on cardiovascular risk in a cross- sectional cohort: Cardiovascular Injury due to Tobacco Use study
R. Keith (2018)
10.1111/bcp.13393
Population pharmacokinetic model of transdermal nicotine delivered from a matrix‐type patch
Matthew W Linakis (2017)
10.3389/fnbeh.2016.00253
Racemic Salsolinol and its Enantiomers Act as Agonists of the μ-Opioid Receptor by Activating the Gi Protein-Adenylate Cyclase Pathway
Pablo Berríos-Cárcamo (2017)
10.1152/ajplung.00343.2016
Biomarkers of exposure to new and emerging tobacco delivery products.
S. Schick (2017)
10.1093/ntr/ntw264
One-Year Smoking Trajectories Among Established Adult Smokers With Low Baseline Motivation to Quit
A. Mathew (2017)
10.1124/jpet.116.237594
Predictors of Variation in CYP2A6 mRNA, Protein, and Enzyme Activity in a Human Liver Bank: Influence of Genetic and Nongenetic Factors
J. Tanner (2017)
10.1039/c7cc00243b
Rapid detection of nicotine from breath using desorption ionisation on porous silicon.
T. Guinan (2017)
Title : Predictors of variation in CYP 2 A 6 mRNA , protein , and enzyme activity in a human liver bank : influence of genetic and non-genetic factors
Julie-Anne Tanner (2016)
10.1016/B978-0-12-800213-1.00013-4
Brain Orexin Receptors and Nicotine
R. Machaalani (2016)
10.3343/alm.2016.36.5.427
Evaluation of Serum Cotinine Cut-Off to Distinguish Smokers From Nonsmokers in the Korean Population
K. Ko (2016)
10.1002/lary.25290
Self‐reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer
S. Khariwala (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar